Department of Science and Technology
Department of Science and Technology
The UK Medical Research Council (MRC), and the Department of Science and Technology (DOST) through the Philippine Council for Health and Research Development (PCHRD) invite concept proposals to the second UK-Philippines Joint Health Research Call.
This initiative will provide funding for high quality 3-year collaborative research projects focusing on Communicable and Non-Communicable Diseases of relevance to the Philippines. This exciting initiative builds on the MRC-PCHRD Call launched in 2015 through which 6 proposals addressing research needs in Infectious Diseases were funded.
The second call being launched by MRC and PCHRD aims to further build on the strengths of the UK and Filipino research base by funding innovative partnerships in Communicable as well as Non-Communicable Diseases of relevance to the Philippines. While the 2015 call focused entirely on Infectious Disease research, this second call aims to enable opportunities for partnership in the areas of Infectious Diseases, and Type 2 Diabetes Mellitus (T2DM).
Based on the latest Philippine health statistics, the NCD burden in the Philippines has been steadily increasing over the last decade. NCDs are now the leading cause of morbidity in the country, and mortality rates have been steadily rising in the last 35 years, with the greatest increases noted within the last two decades. In particular, the mortality trend from T2DM in the Philippines has been rising steadily, with 14.1, 25.5, and 27.2 deaths per 100,000 population in 2000, 2008, and 2013 respectively, as shown in Philippine Health Statistics data. The 2008 Philippine National Nutrition Survey also reported that prevalence rates for DM type 2 increased progressively from age 30 years and peaked among the age groups 50-59 and 60-69 years. The joint funders hope that collaborations between UK and Filipino researchers will increase capability for understanding and tackling the growing burden of T2DM.
Objectives and scope
1. Communicable diseases of relevance to the Philippines, particularly on diseases that impact the most vulnerable in society, specifically:
· Influenza-like illness
· Chronic respiratory infections including Pneumonia
· Zika Virus
Areas of particular research interest within the infectious disease space include but are not limited to:
· Genomics and molecular technologies: for novel biomarker identification, with a focus on host and pathogen ‘omics and host-pathogen interactions
· Diagnostics: Development of cost effective, rapid diagnostic tools, utilizing off-patent/ lapsed and/or novel technologies. Specific topics include the following:
o Point of care
§ Diagnostic test done at the time and place of patient care
o Screening / confirmatory /prognostic
§ Screening to detect early disease or risk factors for disease
§ Confirming the presence or absence of disease
§ Prognosticating and to predicting the likely outcome of disease, susceptibility and chances of recovery
o Information and Communication Technology (ICT)/e-health: Development of user-friendly ICT solutions to accelerate the gathering and processing of health and related information for policymaking, and delivery of quality healthcare services
2. Non- Communicable Diseases (NCDs), specifically; Type 2 Diabetes Mellitus
Areas of particular research interest include but are not limited to:
· Use of animal models in identifying the genes responsible for development of or protection from the disease
· Studies on creation/ use of animal models for therapeutic trials
· Development of cost-effective biomedical devices for diagnosing, treatment, and/or management T2DM among Filipinos
The total funding available for this call is as follows:
MRC - up to £2 million pounds (Funding provided to the successful UK applicants)
PCHRD – up to £1.25 million pounds/ Php 80 million Pesos (Funding provided to the successful Filipino applicants)
Up to £650 thousand pounds will be available per partnership (up to£400K from UK and up to £250K/ Php 16 million Pesos from Philippines) to support activities for up to 3 years.
It is expected that this funding will support around 6 joint projects; up to 4 in Infectious Diseases and up to 2 in Diabetes Mellitus.
Applications will be required to have one UK Principal Investigator and one Filipino Principal Investigator. If appropriate, applications with industrial partners are welcomed (although no funding will be available to these partners).
Assessment Process and decision making process
To be funded, proposals must be internationally competitive and at a standard equivalent to that normally expected to be supported by each funding organisation.
· Significance and potential impact of the research
· Scientific Rationale: novelty, importance and timeliness of the research
· Design and feasibility of the Project Plan
· Partnership: including strength and clarity of collaborations and opportunities provided, quality of the project management structure proposed
· Quality and suitability of the research environment and of the facilities
· Value for money for Filipino and UK science
· Ethical considerations and governance arrangements
In addition, applicants must describe how the proposed UK funded work is ODA compliant (approximately 150 words). This section will be made publicly available. For further information on ODA, please visit: http://www.newtonfund.ac.uk/about/what-is-oda/
Researchers with successful concept proposals will be invited to submit a full proposal. To enhance the quality of the partnership and support the development of high quality full stage proposals, MRC and PCHRD will be making travel grants (up to £3K) available for full proposal development. Only applicants from the shortlisted concept proposals will be invited to submit full proposals in October 2017.
Funding decision process for this Call will be the following:
June 2017: Concept proposals will undergo Panel review facilitated by MRC and PCHRD
July 2017: Successful applicants to be informed and travel grants released. Proponents from the shortlisted concept proposals will be asked to jointly develop full proposals
October 2017: Joint applications (full proposal) will be received from the invited UK and Filipino PIs
October 2017: MRC and PCHRD will carry out eligibility and internal checks and agree which proposals will go forward for technical review.
November 2017 - January 2018: A joint peer review will be conducted, including UK and Filipino academic reviewers (plus other international reviewers as appropriate) to assess merits of the proposals and provide funding recommendations to MRC and PCHRD
Spring 2018: MRC and the DOST-PCHRD Governing Council will decide on final list of approved proposal, based recommendations made by the technical review panel.
October 2018: Awards start
For further information, UK applicants should contact:
For further information, Filipino applicants should contact:
For more information on how to apply, you may refer to the Joint Health Research Call Guidance and DOST-GIA Guidelines.
The Philippine Council for Health Research and Development is now accepting capsule research proposals for possible funding in CY 2018. Priority topics for the capsule research proposals are enumerated per research area as follows:
Diagnostics - Development of diagnostics for early detection and/or prediction of disease and mortality, utilizing existing technologies and/or novel technology. Such technology will also look at the genetic or biological markers associated with lifestyle diseases such as diabetes mellitus, cardiovascular diseases and cancer. The diagnostics can be point of care, screening, confirmatory, prognostic. Possible technologies for research include:
· Latex agglutination
· Lateral flow assay/Dipstick
· Isothermal technology
· Biosensors/Chemical sensors
· Nucleic Acid Testing
· Lab-on-a-chip (Microfluidics, paper technology, Nanotechnology, Aptamers or a combination of)
· Radio-labelled assays
Proof of concept for point of care, screening, confirmatory and prognosis for the following priority diseases: tropical diseases (including neglected diseases); malignant neoplasms; emerging infectious diseases; neurodegenerative and mental health disorders; diseases associated with multi-drug resistance; metabolic diseases, diabetes and other endocrine-related diseases; auto-immune/immunologic diseases and deficiencies; cerebrovascular; diseases of the cardiovascular system; HIV-AIDS; GUT, GIT and hepatitis; respiratory diseases; and, tuberculosis (all forms).
Functional Foods - Food or food components that provide health benefits beyond basic nutrient function; Involves determination of health benefits and safety assessment of food or food components in reducing risk for disease occurrence, specifically lifestyle related diseases such as cardiovascular disease, diabetes, and cancer.
· Characterization, safety assessment, establishment of health benefits and product development of local fruits (guyabano, tiesa,), local vegetables (okra, saluyot), rootcrops, tuber and starchy food (yacon, sago, purple yam), rice (pigmented), local berries (duhat, lipote, aratiles, bignay), Herbs and spices (tanglad, pandan), nuts (pili), seaweeds (lato, red seaweeds) and edible mushroom.
· Safety assessment, establishment of health benefits and product development of mangosteen, malunggay, sweet potato varieties, and ginger.
Molecular technologies for health - Utilization of molecular technology platforms in developing local technologies for the development of personalized medicines, diagnostics, therapeutics as support to health and clinical practice guidelines and policies
Omics Technologies for Health and Wellness
Bioinformatics and Systems Biology
Novel Technologies for Therapeutics
Biobanking, Data Mining and Population Studies for Human Health, Ethnicity and Forensic Applications
Hospital Equipment and Biomedical Devices - Design and development of affordable, safe, and reliable hospital equipment and biomedical devices
Design and development of hospital equipment and biomedical devices for the following:
Information and Communication Technology (ICT) for Health - User-friendly ICT solutions to accelerate the gathering and processing of health and related information for policymaking and delivery of quality health care services
Dengue - Dengue R and D intends to reduce transmission of dengue and development of an early warning system for the prediction of dengue outbreak.
Vector surveillance and IVM
Dengue Outbreak Response
Disaster Risk Reduction - Innovations which will reduce risks to health; Based on the Sendai Framework
Health and Climate Change Adaptation - Covers cross-cutting researches on climate change adaptation, which have direct implications on public health
Who may submit
Filipinos with at least a Master’s Degree in a relevant field, have proven research competence / track record, and employed in universities/colleges, research agencies/institutes, hospitals, and other health related agencies are eligible to apply for the research grant/ funding assistance.
How to submit
Submit the capsule proposal and curriculum vitae of the proponent to:
Dr. Jaime C. Montoya
Philippine Council for Health Research and Development
Department of Science and Technology
3rd Floor, DOST Main Bldg.
Gen. Santos Avenue
Bicutan, Taguig City, Metro Manila
Deadline for submission of capsule proposals: 31 May 2017